Consonance closes oversubscribed healthcare fund at $1.35B
What's the deal? Consonance Capital PartnersDealroom has a profile for this one. Try Dealroom → has closed its third fund, Consonance Private Equity III, at $1.35 billion. The US healthcare private equity firm hit its hard cap in a heavily oversubscribed process, backed by existing limited partners and a select group of new investors.
Why now? Consonance reached its final close after just under four months in the market. The firm credited the pace to investor confidence and the strength of its existing relationships.
What's the endgame? Like its predecessors, Fund III targets US healthcare companies in the lower and middle market. The firm backs businesses focused on efficiency, cost containment, and high-quality patient care through growth equity, buyouts, carve-outs, recapitalisations, and special situations.
The fund drew a global investor mix, including endowments and foundations, pension plans, and financial institutions. Monument GroupDealroom has a profile for this one. Try Dealroom → served as global placement agent, with Latham & WatkinsDealroom has a profile for this one. Try Dealroom → as legal counsel.
The firm's managing partners said they were "thrilled to close Fund III at its hard cap" and credited management teams at portfolio companies as "major contributors to these results."
The signal: A four-month final close at hard cap signals steady appetite for healthcare-focused private equity, even as fundraising timelines stretch across much of the industry. Investors are still paying up for managers with a track record in cost-conscious care.
Read more: wallstreet-online.de
Image credit: Generated with Gemini
